[25] Analysis of inhibition of retroviral reverse transcriptase
- 1 January 1996
- book chapter
- Published by Elsevier in Methods in Enzymology
- Vol. 275, 472-502
- https://doi.org/10.1016/s0076-6879(96)75027-9
Abstract
No abstract availableThis publication has 74 references indexed in Scilit:
- Synergistic Inhibition of HIV-1 Reverse Transcriptase DNA Polymerase Activity and Virus Replication in Vitro by Combinations of Carboxanilide Nonnucleoside CompoundsBiochemistry, 1995
- Carboxanilide Derivative Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase Interact with Different Mechanistic Forms of the EnzymeBiochemistry, 1995
- Locations of Anti-AIDS Drug Binding Sites and Resistance Mutations in the Three-dimensional Structure of HIV-1 Reverse TranscriptaseJournal of Molecular Biology, 1994
- Enzymatic properties and sensitivity to inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase with Glu-138→Arg and Tyr-188→His mutationsAntiviral Research, 1994
- Characterization of HIV-1 Strains Isolated from Patients Treated with TIBO R82913AIDS Research and Human Retroviruses, 1994
- A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templatesAntiviral Research, 1991
- The inhibition of human immunodeficiency virus type 1 reverse transcriptase by avarol and avarone derivativesFEBS Letters, 1990
- Mechanism of HIV reverse transcriptase: enzyme-primer interaction as revealed through studies of a dNTP analog, 3'-azido-dTTPBiochemistry, 1990
- Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivativeBiochemical and Biophysical Research Communications, 1989
- Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitroBiochemical and Biophysical Research Communications, 1987